Given that this study is a retrospective review of a relatively small sample of anti‐TIF1‐γ‐positive DM, further comparison studies among different kinds of MSA based on larger cohorts of patients are required to confirm our conclusions. Here, TRIM33 is linked to dermatomyositis.